COMMUNIQUÉS West-GlobeNewswire

Immunomedics Announces Departure of Chief Medical Officer

29/04/2019 - 13:35

MORRIS PLAINS, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Dova Pharmaceuticals Receives Positive Opinion from CHMP for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

29/04/2019 - 13:30

Positive Opinion based on positive efficacy and safety data from two Phase 3 clinical trials DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Committee for [...]

Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials

29/04/2019 - 13:30

Partnership yields the first investment from newly launched MMRF Myeloma Investment Fund GAITHERSBURG, Md. and NORWALK, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- NexImmune and the Multiple Myeloma Research Foundation ( [...]

Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy

29/04/2019 - 13:30

Intellia scientists advance CRISPR-mediated targeted gene insertion in non-human primates Achieved normal circulating human Factor IX protein levels in non-human primates using targeted gene insertion High rate and [...]

The Hawkesbury and District General Hospital Licenses TREAT as Part of the Regionalized Expansion of the TREAT EHR Through Ottawa Hospital

29/04/2019 - 13:30

TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the licensing of the TREAT EHR to the Hawkesbury and District General Hospital (HGH). The Hawkesbury and [...]

Block Listing Interim Review

29/04/2019 - 13:30

BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 29 April 2019 Name of applicant : Summit Therapeutics plc Name of scheme: 2005 EMI Scheme Period of [...]

Biogen Announces Three New Nominees for Election to Board of Directors

29/04/2019 - 13:30

Nominees Bring Decades of Management and Global Operating Experience, Including at Leading Healthcare Companies CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) today announced the nomination [...]

Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting

29/04/2019 - 13:04

Voyager’s vectorized antibody program directed against tau demonstrates antibody distribution and expression levels in specific cell types that further facilitate studies with a vectorized antibody in animal models of [...]

Axsome Therapeutics To Report First Quarter 2019 Financial Results On May 9, 2019

29/04/2019 - 13:00

Axsome to host conference call and webcast on Thursday, May 9, 2019 at 8:00 AM Eastern Time NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical [...]

Share buy-back week 17/2019

29/04/2019 - 11:14

Announcement 29 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]

ASLAN Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update

29/04/2019 - 11:02

SINGAPORE, April 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets, [...]

ViroGates Releases First Quarter 2019 Results

29/04/2019 - 10:33

Company announcement no. 8-2019 Birkerød, 29 April 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for the [...]

Revised Financial Calendar 2019

29/04/2019 - 10:31

Company announcement no. 7-2019 Birkerød, 29 April 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO) has revised its financial calendar for 2019: 20 March Deadline for submission of business to be transacted at the [...]

Olainfarm signs a new 3 million euro worth supply contract with the World Health Organization

29/04/2019 - 10:05

JSC Olainfarm has won the International World Health Organization (WHO) tender for the supply of anti-tuberculosis agent PASS sodium in 2019 - 2020. Based on the results of the tender, WHO and Latvian pharmaceutical [...]

Remedent Inc. strengthened its participation in the global dental venture of tomorrow Metrics in Balance NV

29/04/2019 - 09:00

GHENT, Belgium, April 29, 2019 (GLOBE NEWSWIRE) -- On March 29 th , 2019 Remedent Inc. (OTCBB:REMI.OB) participated, through its 99,99% Belgian daughter company REMEDENT NV, in the contribution in kind of the Belgian [...]

Wildflower mise en avant dans la publication de NetworkNewsWire sur la croissance exponentielle de l'industrie du cannabis

29/04/2019 - 08:30

NEW YORK, 29 avr. 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) a annoncé aujourd'hui son apparition dans une rubrique éditoriale publiée par NetworkNewsWire (« NNW »), [...]

Mereo BioPharma Group Plc ("Mereo" or the "Company" or the "Group") Preliminary Results for the Year Ended December 31, 2018 -- Strong Operational Progress

29/04/2019 - 08:00

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION IS NOW CONSIDERED IN THE PUBLIC DOMAIN. LONDON, April [...]

Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events

29/04/2019 - 07:30

For Information Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events April 29, 2019 Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, [...]

Nicox : Participation à des conférences d’industrie pharmaceutique et financière

29/04/2019 - 07:30

Pour Information Nicox : Participation à des conférences d’industrie pharmaceutique et financière 29 Avril Sophia Antipolis, France Nicox SA (Euronext Paris: FR0013018124, COX, éligible PEA-PME), une société [...]